Evidence map›Paper›PMID 31085625›Full record

ArticleEMBO reports2019

The nucleoporin ELYS regulates nuclear size by controlling NPC number and nuclear import capacity.

Predrag Jevtić, Andria C Schibler, Chase C Wesley, Gianluca Pegoraro, Tom Misteli, Daniel L Levy

Open access · hybridAbstract read
In one paragraph

Article in EMBO reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. How the chromatin landscape influences nuclear morphology.Frontiers in cell and developmental biology · 2025
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Manipulation of Embryonic Cleavage Geometry Using Magnetic Tweezers.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  16. Nuclear growth and import can be uncoupled.Molecular biology of the cell · 2024
    Article
  17. Review
  18. Article
  19. Nuclear transport proteins: structure, function, and disease relevance.Signal transduction and targeted therapy · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Predrag JevtićDepartment of Molecular Biology, University of Wyoming, Laramie, WY, USA.
Andria C SchiblerNational Cancer Institute, NIH, Bethesda, MD, USA.
Chase C WesleyDepartment of Molecular Biology, University of Wyoming, Laramie, WY, USA.
Gianluca PegoraroHigh Throughput Imaging Facility (HiTIF), National Cancer Institute, NIH, Bethesda, MD, USA.
Tom MisteliNational Cancer Institute, NIH, Bethesda, MD, USA mistelit@mail.nih.gov dlevy1@uwyo.edu.ORCID 0000-0003-3530-3020
Daniel L LevyDepartment of Molecular Biology, University of Wyoming, Laramie, WY, USA mistelit@mail.nih.gov dlevy1@uwyo.edu.ORCID 0000-0002-7853-3275
National Cancer Institute · USUniversity of Wyoming · US

Funding

HiTIF Microscopy Core FacilityZICBC011567 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI PEGORARO, GIANLUCA · 2014 to 2025
$15.8M
Integration of Xenopus extract and microfluidics to study organelle size scalingR01GM113028 · NIGMS · UNIVERSITY OF WYOMING · PI LEVY, DANIEL LEON · 2015 to 2019
$1.3M
NIGMS NIH HHS R01 GM113028
6 · The paper itself

Abstract

How intracellular organelles acquire their characteristic sizes is a fundamental question in cell biology. Given stereotypical changes in nuclear size in cancer, it is important to understand the mechanisms that control nuclear size in human cells. Using a high-throughput imaging RNAi screen, we identify and mechanistically characterize ELYS, a nucleoporin required for post-mitotic nuclear pore complex (NPC) assembly, as a determinant of nuclear size in mammalian cells. ELYS knockdown results in small nuclei, reduced nuclear lamin B2 localization, lower NPC density, and decreased nuclear import. Increasing nuclear import by importin α overexpression rescues nuclear size and lamin B2 import, while inhibiting importin α/β-mediated nuclear import decreases nuclear size. Conversely, ELYS overexpression increases nuclear size, enriches nuclear lamin B2 at the nuclear periphery, and elevates NPC density and nuclear import. Consistent with these observations, knockdown or inhibition of exportin 1 increases nuclear size. Thus, we identify ELYS as a novel positive effector of mammalian nuclear size and propose that nuclear size is sensitive to NPC density and nuclear import capacity.

Indexed as

Active Transport, Cell NucleusBiomarkersCell Line, TumorCell NucleusDNA-Binding ProteinsGene Expression ProfilingGene Knockdown TechniquesHumansMolecular ImagingNuclear PoreNuclear Pore Complex ProteinsProtein BindingRNA InterferenceRNA, Small InterferingTranscription FactorsAHCTF1 protein, humanBiomarkersDNA-Binding ProteinsNuclear Pore Complex ProteinsRNA, Small InterferingTranscription FactorsELYSnuclear pore complexnuclear sizenucleocytoplasmic transportnucleus

Identifiers

PMID31085625
PMCPMC6549122
OpenAlexW2908103441

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.